ATOSSA THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
ATOSSA THERAPEUTICS, INC. (ATOS) reported Increase (Decrease) in Other Noncurrent Assets of -$711.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$711.00K, a 6563.64% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$343.00K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $329.00K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$4.00K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$331.00K, a 119.51% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $1.70M, a 184.25% increase from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $597.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$711.00K 10-Q · filed 2026-08-07 | -$1.05M derived: sum of 3 quarters · filed 2026-08-07 | -$725.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$711.00K 10-Q · filed 2026-05-08 | -$1.05M derived: sum of 2 quarters · filed 2026-05-08 | -$725.00K derived: sum of 3 quarters · filed 2026-05-08 | -$726.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | -$343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$14.00K derived: sum of 2 quarters · filed 2026-03-25 | -$15.00K derived: sum of 3 quarters · filed 2026-08-07 | -$4.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $329.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $328.00K derived: sum of 2 quarters · filed 2026-08-07 | $339.00K 10-Q · filed 2025-11-12 | -$32.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $10.00K 10-Q · filed 2026-08-07 | -$361.00K derived: sum of 3 quarters · filed 2026-08-07 | -$432.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $11.00K 10-Q · filed 2026-05-08 | -$360.00K derived: sum of 2 quarters · filed 2026-05-08 | -$431.00K derived: sum of 3 quarters · filed 2026-05-08 | -$320.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$442.00K derived: sum of 2 quarters · filed 2026-03-25 | -$331.00K derived: sum of 3 quarters · filed 2026-03-25 | -$331.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $40.00K derived: sum of 2 quarters · filed 2025-11-12 | $40.00K 10-Q · filed 2025-11-12 | $40.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $111.00K 10-Q · filed 2025-08-12 | $111.00K derived: sum of 3 quarters · filed 2025-08-12 | $1.81M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $1.70M derived: sum of 3 quarters · filed 2025-05-13 | $1.70M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $1.70M derived: sum of 2 quarters · filed 2025-03-25 | $1.70M derived: sum of 3 quarters · filed 2025-03-25 | $1.70M 10-K · filed 2025-03-25 | |
| 2023-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.70M derived: sum of 2 quarters · filed 2024-11-12 | $1.70M 10-Q · filed 2024-11-12 | $0.00 10-Q · filed 2023-11-13 | $1.70M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | $0.00 derived: sum of 3 quarters · filed 2024-08-12 | $0.00 derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | -$1.00K 10-Q · filed 2024-05-13 | -$1.00K derived: sum of 2 quarters · filed 2024-05-13 | -$1.00K derived: sum of 3 quarters · filed 2024-05-13 | $596.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $597.00K derived: sum of 3 quarters · filed 2024-04-01 | $597.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $597.00K derived: sum of 2 quarters · filed 2023-11-13 | $597.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $597.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $597.00K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |